Citigroup Inc. Cuts Stock Position in OptimizeRx Co. (NASDAQ

Citigroup Inc. decreased its position in shares of OptimizeRx Co. (NASDAQ:OPRX – Free Report) by 45.0% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,189 shares of the company’s stock after selling 5,070 shares during the period. Citigroup Inc.’s […]

Related Keywords

Canada , Marion Odence Ford , Stifel Nicolaus , Optimizerx Company Profile , Citigroup Inc , Investment Company Inc , Kennedy Capital Management , Optimizerx Corporation , Securities Exchange Commission , Barclays , Nasdaq , Exchange Commission , Royal Bank , Optimizerx Co , Free Report , Capital Management , Sigma Advisers , Two Sigma Investments , Sigma Investments , General Counsel Marion Odence Ford , Evidence Based Physician Engagement , Care Banner , Visit Holdingschannel , Optimizerx Daily , Optimizerx , Nasdaq Oprx , Oprx , Computer And Technology , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,